Regulations.gov document
Determination That LUPRON (Leuprolide Acetate) Injection, 1 Milligram/0.2 Milliliter, Was…
Notice · FDA-2018-P-4851 · posted May 30, 2019
Key facts
| Document ID | FDA-2018-P-4851-0008 |
|---|---|
| Title | Determination That LUPRON (Leuprolide Acetate) Injection, 1 Milligram/0.2 Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Document type | Notice |
| Subtype | Determinations |
| Agency | FDA |
| Docket | FDA-2018-P-4851 |
| Posted | May 30, 2019 |
| Federal Register citation | 84 FR 25060 |
| FR document number | 2019-11243 |
| Comment period opens | May 30, 2019 |
| Effective date | May 30, 2019 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: